AGM.L

Applied Graphene Materials Plc
Applied Graphene - Strategic Review Update
28th December 2022, 07:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 9734K
Applied Graphene Materials PLC
28 December 2022
 

This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR").

28 December 2022

Applied Graphene Materials plc

("Applied Graphene Materials", "the Company" or "the Group")

Strategic Review Update

On 23 November 2022, the Company announced the initiation of a strategic review, including consideration of the options available to maximise value for the Company's shareholders and other stakeholders.

The Board confirms that various non-binding indicative proposals have now been received from interested parties for the sale of the Group's trade and assets or of the shares in the Group's main operating subsidiary. The Board, in conjunction with Alvarez & Marsal Europe LLP (the financial adviser appointed by the Company to manage the strategic review process), is in discussions with the  various parties involved with a view to eliciting final proposals in early January 2023. The Board's intention would then be to select a preferred party with whom to progress a transaction to completion. Some of the proposals submitted would require interim financing in order to be progressed to completion, which the relevant parties involved in the process are aware of.

Current discussions with interested parties may be altered or terminated at any time and, accordingly, there can be no certainty that any final proposals will be made, nor as to the terms on which any such final proposals may be made. 

The Board previously notified that the Company has sufficient working capital to continue in operation until 31 January 2023. The Board continues to take action to seek to protect the financial position of the Company, its shareholders and creditors in the event that the strategic review does not achieve a satisfactory conclusion. In parallel with the strategic review, the process of statutory redundancy consultations with the Group's employees announced on 23 November 2022 is therefore ongoing.

The Board will continue to update shareholders further as appropriate.

For further information, please contact:

Applied Graphene Materials  +44 (0) 1642 438 214

Adrian Potts, Chief Executive Officer

David Blain, Chief Financial Officer

Alvarez & Marsal Europe LLP +44 (0) 784 107 2042

Alex Baird  abaird@alvarezandmarsal.com

Singer Capital Markets  (Nominated Adviser and Joint Broker) +44 (0) 207 496 3000

Peter Steel / Oliver Platts

Allenby Capital Limited (Joint Broker) +44 (0) 203 328 5656

Nick Athanas / George Payne (Corporate Finance)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAPAXASPAFFA ]]>
TwitterFacebookLinkedIn